Biblio

Export 3173 results:
Author Title Type [ Year(Desc)]
2024
X. Zhang, Haeri, M., Swerdlow, R. H., and Wang, N., “Loss of Adaptive DNA Breaks in Alzheimer's Disease Brains.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1861-1875, 2024.
A. Sofia Costa, Exalto, L. G., van der Flier, W. M., Teunissen, C. E., Barkhof, F., Kuijf, H. J., and Biessels, G. Jan, “Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease.”, J Alzheimers Dis, vol. 102, no. 4, pp. 981-986, 2024.
N. H. Stricker, Christianson, T. J., Pudumjee, S. B., Polsinelli, A. J., Lundt, E. S., Frank, R. D., Kremers, W. K., Machulda, M. M., Fields, J. A., Jack, C. R., Knopman, D. S., Graff-Radford, J., Vemuri, P., Mielke, M. M., and Petersen, R. C., “Mayo Normative Studies: Amyloid and Neurodegeneration Negative Normative Data for the Auditory Verbal Learning Test and Sex-Specific Sensitivity to Mild Cognitive Impairment/Dementia.”, J Alzheimers Dis, vol. 100, no. 3, pp. 879-897, 2024.
C. M. Keith, Haut, M. W., Teixeira, C. Vieira Lig, Mehta, R. I., Phelps, H., Ward, M., Miller, M., R Navia, O., Coleman, M. M., Marano, G., Wang, X., Pockl, S., Rajabalee, N., Scarisbrick, D. M., McCuddy, W. T., D'Haese, P. - F., Rezai, A., and Wilhelmsen, K., “Memory consolidation, temporal and parietal atrophy, and metabolism in amyloid-β positive and negative mild cognitive impairment.”, J Alzheimers Dis, vol. 102, no. 3, pp. 778-791, 2024.
F. A. Ramadan, Arani, G., Jafri, A., Thompson, T., Bland, V. L., Renquist, B., Raichlen, D. A., Alexander, G. E., and Klimentidis, Y. C., “Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 3, pp. 1069-1078, 2024.
C. Jan Stam and de Haan, W., “Network Hyperexcitability in Early-Stage Alzheimer's Disease: Evaluation of Functional Connectivity Biomarkers in a Computational Disease Model.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1333-1348, 2024.
H. Guo, Sun, S., Yang, Y., Ma, R., Wang, C., Zheng, S., Wang, X., and Li, G., “A Novel Score to Predict Individual Risk for Future Alzheimer's Disease: A Longitudinal Study of the ADNI Cohort.”, J Alzheimers Dis, vol. 101, no. 3, pp. 923-936, 2024.
O. Almkvist, Larsson, M., and Graff, C., “Odor Identification Across Time in Mutation Carriers and Non-Carriers in Autosomal-Dominant Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 587-598, 2024.
A. S. Buchman, Yu, L., Oveisgharan, S., Zammit, A. R., Wang, T., Shulman, J. M., VanderHorst, V., Nag, S., and Bennett, D. A., “Parkinson's Disease and Other Alzheimer's Disease and Related Dementia Pathologies and the Progression of Parkinsonism in Older Adults.”, J Alzheimers Dis, vol. 100, no. s1, pp. S197-S209, 2024.
K. Ishii, Yamada, T., Hanaoka, K., Kaida, H., Kojita, Y., Kono, A., Hanada, K., Saigoh, K., Sakuta, S., Hashimoto, M., Kato, T., and Nakamura, A., “Regional differences in glucose metabolic decline and tau deposition in the Alzheimer's continuum brain.”, J Alzheimers Dis, vol. 102, no. 1, pp. 228-236, 2024.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B., “The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”, J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
Y. Okinaka, Shinagawa, Y., Claussen, C., Gul, S., Matsui, I., Matsui, Y., and Taguchi, A., “RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1673-1683, 2024.
M. Safieh, Liraz, O., Ovadia, M., and Michaelson, D., “The Role of Impaired Receptor Trafficking in Mediating the Pathological Effects of APOE4 in Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 2, pp. 753-775, 2024.
F. H. Duits, Nilsson, J., Zetterberg, H., Blennow, K., van der Flier, W. M., Teunissen, C. E., and Brinkmalm, A., “Serial Cerebrospinal Fluid Sampling Reveals Trajectories of Potential Synaptic Biomarkers in Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S103-S114, 2024.
K. Kitagawa, Toi, S., Hosoya, M., Seki, M., Yamagishi, S., Hoshino, T., and Yoshizawa, H., “Small Vessel Disease Burden Predicts Incident Dementia and Poor Functional Outcome in Independent Outpatients.”, J Alzheimers Dis, vol. 101, no. 3, pp. 751-760, 2024.
M. J. Angevaare, Pieters, J. A., Twisk, J. W. R., and Van Hout, H. P. J., “Social Activity and Cognitive Decline in Older Residents of Long-Term Care Facilities: A Cohort Study.”, J Alzheimers Dis, vol. 98, no. 2, pp. 433-443, 2024.
A. Payen, Bateman, J. R., Muralidhara, S. Dhanavanth, Sachs, B. C., Cleveland, M., Yang, M., Lockhart, S. N., Craft, S., and Bennett, J. M., “Social support may buffer the effect of ε4 allele on cognition in older adults.”, J Alzheimers Dis, vol. 102, no. 4, pp. 967-974, 2024.
Y. Shin Park, Joo, H. Jin, Jang, Y. Seo, Jeon, H., Park, E. - C., and Shin, J., “Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.”, J Alzheimers Dis, vol. 97, no. 1, pp. 273-281, 2024.
W. Wang, Zhao, F., Torres, S., Harris, P. L. R., Wang, X., Peng, L., Siedlak, S. L., and Zhu, X., “Space-Like Irradiation Exacerbated Cognitive Deficits and Amyloid Pathology in CRND8 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S327-S339, 2024.
L. Sannemann, Bartels, C., Brosseron, F., Buerger, K., Fliessbach, K., Freiesleben, S. Dawn, Frommann, I., Glanz, W., Heneka, M. T., Janowitz, D., Kilimann, I., Kleineidam, L., Lammerding, D., Laske, C., Munk, M. H. J., Perneczky, R., Peters, O., Priller, J., Rauchmann, B. - S., Rostamzadeh, A., Roy-Kluth, N., Schild, A. - K., Schneider, A., Schneider, L. - S., Spottke, A., Spruth, E. Jakob, Teipel, S., Wagner, M., Wiltfang, J., Wolfsgruber, S., Duezel, E., and Jessen, F., “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
A. Memon, Moore, J. A., Kang, C., Ismail, Z., and Forkert, N. D., “Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 2, pp. 623-637., 2024.
2025
P. Grau-Jurado, Mostafaei, S., Xu, H., Mo, M., Petek, B., Kalar, I., Naia, L., Kele, J., Maioli, S., Pereira, J. B., Eriksdotter, M., Chatterjee, S., and Garcia-Ptacek, S., “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
D. A. Levine, Sussman, J. B., Hayward, R. A., Gałecki, A. T., Whitney, R. T., Briceño, E. M., Gross, A. L., Giordani, B. J., Elkind, M. Sv, Gottesman, R. F., Gaskin, D. J., Sidney, S., Yaffe, K., and Burke, J. F., “The potential impact of optimal blood pressure treatment intensity to reduce disparities in dementia between Black and White individuals.”, J Alzheimers Dis, p. 13872877241302506, 2025.

Pages